About GPO   |   Newsroom/Media   |   Congressional Relations   |   Inspector General   |   Careers   |   Contact   |   askGPO   |   Help  
 
Home   |   Customers   |   Vendors   |   Libraries  

The Electronic Code of Federal Regulations (e-CFR) is a regularly updated, unofficial editorial compilation of CFR material and Federal Register amendments produced by the National Archives and Records Administration's Office of the Federal Register (OFR) and the Government Printing Office.

Parallel Table of Authorities and Rules for the Code of Federal Regulations and the United States Code
Text | PDF

Find, review, and submit comments on Federal rules that are open for comment and published in the Federal Register using Regulations.gov.

Purchase individual CFR titles from the U.S. Government Online Bookstore.

Find issues of the CFR (including issues prior to 1996) at a local Federal depository library.

[1]
 
 

Electronic Code of Federal Regulations

blue pill

e-CFR Data is current as of October 21, 2014

Title 21Chapter ISubchapter DPart 341


TITLE 21—Food and Drugs

CHAPTER I—FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES (CONTINUED)

SUBCHAPTER D—DRUGS FOR HUMAN USE

PART 341—COLD, COUGH, ALLERGY, BRONCHODILATOR, AND ANTIASTHMATIC DRUG PRODUCTS FOR OVER-THE-COUNTER HUMAN USE

rule

Subpart A—GENERAL PROVISIONS

§341.1
Scope.
§341.3
Definitions.
rule

Subpart B—ACTIVE INGREDIENTS

§341.12
Antihistamine active ingredients.
§341.14
Antitussive active ingredients.
§341.16
Bronchodilator active ingredients.
§341.18
Expectorant active ingredient.
§341.20
Nasal decongestant active ingredients.
§341.40
Permitted combinations of active ingredients.
rule

Subpart C—LABELING

§341.70
Labeling of OTC drug products containing ingredients that are used for treating concurrent symptoms (in either a single-ingredient or combination drug product).
§341.72
Labeling of antihistamine drug products.
§341.74
Labeling of antitussive drug products.
§341.76
Labeling of bronchodilator drug products.
§341.78
Labeling of expectorant drug products.
§341.80
Labeling of nasal decongestant drug products.
§341.85
Labeling of permitted combinations of active ingredients.
§341.90
Professional labeling.


For questions or comments regarding e-CFR editorial content, features, or design, email ecfr@nara.gov.
For questions concerning e-CFR programming and delivery issues, email webteam@gpo.gov.